These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

838 related items for PubMed ID: 17192925

  • 21. The challenges facing neurology, neurosurgery, and the neurosciences.
    Swift TR, Ausman JI.
    Arch Neurol; 2005 Dec; 62(12):1814-6. PubMed ID: 16344339
    [No Abstract] [Full Text] [Related]

  • 22. Neurological burden and European investment: a disconnect.
    The Lancet Neurology.
    Lancet Neurol; 2021 Feb; 20(2):81. PubMed ID: 33484649
    [No Abstract] [Full Text] [Related]

  • 23. Where will new drugs come from?
    Lancet; 2011 Jan 08; 377(9760):97. PubMed ID: 21215869
    [No Abstract] [Full Text] [Related]

  • 24. What's holding us back? Understanding barriers to innovation in academic neurosurgery.
    Leuthardt EC.
    Surg Neurol; 2006 Oct 08; 66(4):347-9; discussion 349. PubMed ID: 17015102
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. America's other drug problem: how the drug industry distorts medicine and politics.
    Relman AS, Angell M.
    New Repub; 2002 Dec 16; 227(25):27-41. PubMed ID: 12561803
    [No Abstract] [Full Text] [Related]

  • 28. US government is funding fewer trials as number of industry sponsored trials grows.
    Dyer O.
    BMJ; 2015 Dec 18; 351():h6893. PubMed ID: 26684014
    [No Abstract] [Full Text] [Related]

  • 29. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L.
    Lakartidningen; 2015 Dec 18; 102(39):2737. PubMed ID: 16245544
    [No Abstract] [Full Text] [Related]

  • 30. An assessment of R&D productivity in the pharmaceutical industry.
    Dimitri N.
    Trends Pharmacol Sci; 2011 Dec 18; 32(12):683-5. PubMed ID: 22030299
    [Abstract] [Full Text] [Related]

  • 31. The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration.
    Vitiello B, Heiligenstein JH, Riddle MA, Greenhill LL, Fegert JM.
    Biol Psychiatry; 2004 Jul 01; 56(1):3-9. PubMed ID: 15219466
    [Abstract] [Full Text] [Related]

  • 32. Neurological disease on the global agenda.
    Johnston SC, Hauser SL.
    Ann Neurol; 2008 Jul 01; 64(1):A11-2. PubMed ID: 18668532
    [No Abstract] [Full Text] [Related]

  • 33. Getting back to basics.
    Maricich SM, Zoghbi HY.
    Cell; 2006 Jul 14; 126(1):11-5. PubMed ID: 16839867
    [Abstract] [Full Text] [Related]

  • 34. Addressing the decline in NIH pain research funding.
    Max MB.
    J Pain; 2008 Dec 14; 9(12):1074-6. PubMed ID: 19038769
    [No Abstract] [Full Text] [Related]

  • 35. Grants4Targets: an open innovation initiative to foster drug discovery collaborations.
    Dorsch H, Jurock AE, Schoepe S, Lessl M, Asadullah K.
    Nat Rev Drug Discov; 2015 Jan 14; 14(1):74-6. PubMed ID: 25430867
    [No Abstract] [Full Text] [Related]

  • 36. Comparative effectiveness research in the neurosciences.
    Johnston SC, Hauser SL.
    Ann Neurol; 2009 Feb 14; 65(2):A6-8. PubMed ID: 19260031
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Industry support for medical centers grows.
    Dove A.
    Nat Med; 2000 Sep 14; 6(9):948. PubMed ID: 10973295
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.